Facebook Linkedin RSS Twitter Youtube
Home 2023

Drug licensing

Draft Cell and Gene Therapy Guidance Document Calls for Comparability and Lifecycle Management
Bioprocessing

Draft Cell and Gene Therapy Guidance Document Calls for Comparability and Lifecycle Management

BioNTech, DualityBio Ink Up-to-$1.7B Cancer ADC Collaboration
GEN Edge

BioNTech, DualityBio Ink Up-to-$1.7B Cancer ADC Collaboration

Amgen Breaks Ground on NC Biomanufacturing Facility
Bioprocessing

Amgen Breaks Ground on NC Biomanufacturing Facility

Emergent BioSolutions – COVID-HIG and COVID-EIG
News

Emergent BioSolutions – COVID-HIG and COVID-EIG

Shire Licenses Rare Liver Disease Candidates to $120M Startup Mirum
Featured

Shire Licenses Rare Liver Disease Candidates to $120M Startup Mirum

Novartis Licenses MorphoSys/Galapagos Atopic Dermatitis Candidate MOR106 for $1.1B+
Drug Discovery

Novartis Licenses MorphoSys/Galapagos Atopic Dermatitis Candidate MOR106 for $1.1B+

Glenmark Licenses APC’s Antigen Presenting Cell-Based Anticancer Candidate
Drug Discovery

Glenmark Licenses APC’s Antigen Presenting Cell-Based Anticancer Candidate

PeptiDream Inks Peptide Discovery Platform License with Shionogi
Industry News

PeptiDream Inks Peptide Discovery Platform License with Shionogi

PharmaMar Licenses Rights to Cancer Candidate for Southeast Asia, Australia
Cancer

PharmaMar Licenses Rights to Cancer Candidate for Southeast Asia, Australia

Zai Lab Licenses Paratek’s Late-Stage Aminomethylcycline Antibiotic for China
Drug Discovery

Zai Lab Licenses Paratek’s Late-Stage Aminomethylcycline Antibiotic for China

123...18Page 1 of 18
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.